Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction

被引:30
作者
Bruno, Stefania
Bussolati, Benedetta
Scacciatella, Paolo
Marra, Sebastiano
Sanavio, Fiorella
Tarella, Corrado
Camussi, Giovanni
机构
[1] Univ Turin, Res Ctr Expt Med, Dept Internal Med, Turin, Italy
[2] Osped Maggiore S Giovanni Battista, Dipartimento Med Interna, Cattedra Nefrol, I-10126 Turin, Italy
[3] Osped Maggiore S Giovanni Battista, SCDO Cardiol, I-10126 Turin, Italy
[4] Univ Turin, Div Hematol, Turin, Italy
关键词
G-CSF; GM-CSF; angiogenesis; mobilization; myocardial infarction;
D O I
10.1016/j.cyto.2006.03.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mobilization of endothelial progenitor cells has been suggested to contribute to neo-vascularization of ischemic organs. Aim of this study was to investigate whether the combination of granulocyte colony stimulating factor (6-CSF) and granulocyte-macrophage (GM)-CSF may influence the expansion of circulating KDR+ cells in patients with acute myocardial infarction (AMI). KDR+ cells significantly increased in peripheral blood of AMI patients treated with G-CSF and GM-CSF compared to untreated patients. This KDR+ cells population was CD14(+) but not CD34(+) or CD133(+). CD14(+)/KDR+ cells were also obtained in vitro by culturing mononuclear cells from healthy donors in a Rotary Cell Culture System in the presence of G-CSF + GM-CSF, but not of the individual growth factors. CD14(+)/KDR+ cells, obtained from patients or from in vitro culture, co-expressed hematopoietic (CD45, CD14) and endothelial markers (CD31, CD105, and VE-cadherin). CD14(+)/KDR+, but not CD14(+)/KDR- cells, stimulated the organization of human microvascular endothelial cells into capillary-like structures on Matrigel both in vitro and in vivo. The combination of G-CSF and GM-CSF induced a CD14(+)/KDR+ cell population with potential pro-angiogenic properties. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:56 / 65
页数:10
相关论文
共 33 条
[11]  
Havemann K, 2003, ADV EXP MED BIOL, V522, P47
[12]   Endothelial progenitor cells - Mobilization, differentiation, and homing [J].
Hristov, M ;
Erl, W ;
Weber, PC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (07) :1185-1189
[13]   Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis [J].
Hur, J ;
Yoon, CH ;
Kim, HS ;
Choi, JH ;
Kang, HJ ;
Hwang, KK ;
Oh, BH ;
Lee, MM ;
Park, YB .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (02) :288-293
[14]   Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells [J].
Ingram, DA ;
Caplice, NM ;
Yoder, MC .
BLOOD, 2005, 106 (05) :1525-1531
[15]   Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization [J].
Kalka, C ;
Masuda, H ;
Takahashi, T ;
Kalka-Moll, WM ;
Silver, M ;
Kearney, M ;
Li, T ;
Isner, JM ;
Asahara, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3422-3427
[16]  
Khaoustov VI, 1999, IN VITRO CELL DEV-AN, V35, P501
[17]  
Marra Sebastiano, 2006, EuroIntervention, V1, P425
[18]   Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization [J].
Minamino, K ;
Adachi, Y ;
Okigaki, M ;
Ito, H ;
Togawa, Y ;
Fujita, K ;
Tomita, M ;
Suzuki, Y ;
Zhang, YM ;
Iwasaki, M ;
Nakano, K ;
Koike, Y ;
Matsubara, H ;
Iwasaka, T ;
Matsumura, M ;
Ikehara, S .
STEM CELLS, 2005, 23 (03) :347-354
[19]   Coexpression of endothelial markers and CD14 by cytokine mobilized CD34+ cells under angiogenic stimulation [J].
Nakul-Aquaronne, D ;
Bayle, J ;
Frelin, C .
CARDIOVASCULAR RESEARCH, 2003, 57 (03) :816-823
[20]   Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors [J].
Peichev, M ;
Naiyer, AJ ;
Pereira, D ;
Zhu, ZP ;
Lane, WJ ;
Williams, M ;
Oz, MC ;
Hicklin, DJ ;
Witte, L ;
Moore, MAS ;
Rafii, S .
BLOOD, 2000, 95 (03) :952-958